Effect of semaglutide on alanine aminotransferase in subjects with type 2 diabetes and high cardiovascular risk

被引：0
|
作者：
Sanyal, Arun J. [1 ]
Hansen, Morten [2 ]
Linder, Martin [2 ]
Newsome, Philip N. [3 ]
机构：
[1] Virginia Commonwealth Univ, Div Gastroenterol Hepatol & Nutr, Internal Med, Richmond, VA USA
[2] Novo Nordisk AS, Soborg, Denmark
[3] Queen Elizabeth Hosp Birmingham, Liver Unit, Birmingham, W Midlands, England
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2220
引用
收藏
页码：1175A / 1175A
页数：1
相关论文
共 50 条
  • [1] Will oral semaglutide be used to reduce cardiovascular risk in subjects with type 2 diabetes instead of subcutaneous semaglutide?
    Doggrell, Sheila A.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (05) : 489 - 492
  • [2] Cardiovascular Risk of Semaglutide in Patients With Type 2 Diabetes
    Marso
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (02) : 159 - 159
  • [3] Complex association of serum alanine aminotransferase with the risk of future cardiovascular disease in type 2 diabetes
    Afarideh, Mohsen
    Aryan, Zahra
    Ghajar, Alireza
    Noshad, Sina
    Nakhjavani, Manouchehr
    Baber, Usman
    Mechanick, Jeffrey I.
    Esteghamati, Alireza
    [J]. ATHEROSCLEROSIS, 2016, 254 : 42 - 51
  • [4] A Significant Effect of Oral Semaglutide on Cardiovascular Risk Factors in Patients With Type 2 Diabetes
    Yanai, Hidekatsu
    Hakoshima, Mariko
    Adachi, Hiroki
    Katsuyama, Hisayuki
    [J]. CARDIOLOGY RESEARCH, 2022, 13 (05) : 303 - 308
  • [5] Causes of elevated alanine aminotransferase in Type 2 diabetes
    Morrison, C. L.
    Purewal, T. S.
    Weston, P. J.
    [J]. DIABETIC MEDICINE, 2018, 35 : 159 - 159
  • [6] The effect of semaglutide on liver enzymes in subjects with obesity and elevated alanine aminotransferase: data from a randomised phase 2 trial
    Monk-Hansen, T.
    Van Gaal, L.
    Harrison, S.
    Rasmussen, S.
    Newsome, P. N.
    [J]. DIABETOLOGIA, 2018, 61 : S589 - S589
  • [7] An Indirect Treatment Comparison of the Cardiovascular Protective Effect of Semaglutide vs. Liraglutide in Subjects with Type 2 Diabetes
    Chubb, Barrie
    Bog, Martin
    [J]. DIABETES, 2023, 72
  • [8] The effect of semaglutide on liver enzymes in subjects with obesity and elevated alanine aminotransferase: Data from a randomised Phase 2 trial
    Newsome, P.
    Harrison, S.
    Rasmussen, Soren
    Hansen, T. M.
    Gaal, L. V.
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 : S581 - S581
  • [9] The Effect of Semaglutide on Liver Enzymes in Subjects with Obesity and Elevated Alanine Aminotransferase: Data from a Randomized Phase 2 Trial
    Newsome, Philip N.
    Harrison, Stephen A.
    Rasmussen, Soren
    Fries, Tea Monk
    Van Gaal, Luc
    [J]. HEPATOLOGY, 2018, 68 : 67A - 67A
  • [10] Effects of semaglutide on cardiovascular risk factors and eating behaviors in type 2 diabetes
    Ugo Di Folco
    Noemi Vallecorsa
    Maria Rosaria Nardone
    Angelo Lauria Pantano
    Claudio Tubili
    [J]. Acta Diabetologica, 2022, 59 : 1287 - 1294
12345